Carbamazepine Tablet, Extended Release
Product Images NDC 51407-895

6 FDA label images from Golden State Medical Supply, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 51407-895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Carbamazepine 01)

Chemical Structure (Carbamazepine 01)
Chemical structure of Carbamazepine, showing a tricyclic compound with an amide group attached to a nitrogen atom in the central ring.*
FDA Label Image

Table 1 (Table 1)

Table 1 (Table 1)
A data table titled "Risk by Indication for Antiepileptic Drugs in the Pooled Analysis" showing comparative risk metrics across indications including Epilepsy, Psychiatric, Other, and Total. Columns present placebo and drug patients with events per 1,000 patients, relative risk ratios, and risk differences for additional drug patients with events per 1,000 patients.*
FDA Label Image

Table (Table 2)

Table (Table 2)
A data table titled Dosage Information providing detailed dosing guidelines for Carbamazepine tablets and suspensions by indication and age group. It includes initial dose, subsequent dose, and maximum daily dose for epilepsy under 6 years, ages 6 to 12 years, over 12 years, and trigeminal neuralgia. Dosages are expressed in mg/day or mL/day with distinctions between conventional tablets and extended-release (XR) tablets, as well as suspension dosing instructions.*
FDA Label Image

51407-895-01ol- Carbamazepine 100mg Er Tablets 100s- Rev-05-24.jpg (51407 895 01ol Carbamazepine 100mg Er Tablets 100s Rev 05 24)

51407-895-01ol- Carbamazepine 100mg Er Tablets 100s- Rev-05-24.jpg (51407 895 01ol  Carbamazepine 100mg Er Tablets 100s  Rev 05 24)
Label for Carbamazepine Extended-Release Tablets, USP 100 mg by Golden State Medical Supply, Inc. The label includes dosage form as extended-release tablets, quantity of 100 tablets, and storage instructions. It features a barcode, NDC 51407-895-01, and emphasizes medication guide dispensing and safe storage conditions (20°-25°C).*
FDA Label Image

51407-896-01ol- Carbamazepine 200mg Er Tablets 100s- Rev-05-24.jpg (51407 896 01ol Carbamazepine 200mg Er Tablets 100s Rev 05 24)

51407-896-01ol- Carbamazepine 200mg Er Tablets 100s- Rev-05-24.jpg (51407 896 01ol  Carbamazepine 200mg Er Tablets 100s  Rev 05 24)
Carbamazepine extended-release tablets, USP, 200 mg strength label showing product name, dosage form, quantity of 100 tablets, and manufacturer GSMS Incorporated. Includes instructions to swallow tablets whole and store between 20°-25°C in a tight container. The label has an NDC barcode and safety warnings to keep medication out of children's reach.*
FDA Label Image

51407-897-01ol- Carbamazepine 400mg Er Tablets 100s- Rev-05-24.jpg (51407 897 01ol Carbamazepine 400mg Er Tablets 100s Rev 05 24)

51407-897-01ol- Carbamazepine 400mg Er Tablets 100s- Rev-05-24.jpg (51407 897 01ol  Carbamazepine 400mg Er Tablets 100s  Rev 05 24)
Label for Carbamazepine Extended-Release Tablets, USP 400 mg by Golden State Medical Supply, Inc. The label states the NDC 51407-897-01 and specifies a package size of 100 tablets. It includes medication handling instructions, barcode, and storage conditions (20°-25°C). The label indicates Rx only status and provides a URL for the medication guide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.